Inflation rebates to reduce Medicare payment for 34 Part B drugs

This October through December under the Inflation Reduction Act, Medicare will reduce the beneficiary coinsurance amount for 34 Part B prescription drugs between $1 and $618 per average dose, the Centers for Medicare & Medicaid Services announced recently.

International Price Comparison of Drugs Medicare Is Negotiating

CMS Releases List of New Drugs Subject to Inflation Rebates

Mintz IRA Update — Other Key IRA Programs and Developments: The

Another round of Part B drugs capped by inflation rebates

Prescription Drugs: Spending, Use, and Prices

Federal Register :: Medicare Program; CY 2022 Payment Policies

Inflation Reduction Act Rebates: Changes to Medicare

Inflation Reduction Act: Adjustments to medication pricing

News ASHRM

Chart: The Ever-Increasing Cost of Medicare Drugs

Understanding the Medicare Prescription Drug Rebate - Issue Brief